Evidence map›Paper›PMID 21185944›Full record

ArticleMicrobes and infection2011

Activation of human macrophages by bacterial components relieves the restriction on replication of an interferon-inducing parainfluenza virus 5 (PIV5) P/V mutant.

Caitlin M Briggs, Robert C Holder, Sean D Reid, Griffith D Parks

Abstract read
In one paragraph

Article in Microbes and infection, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Caitlin M BriggsDepartment of Microbiology and Immunology, Wake Forest University, School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157-1064, United States.
Robert C Holder
Sean D Reid
Griffith D Parks
Wake Forest University · US

Funding

CONTROL OF PARAMYXOVIRUS RNA SYNTHESISR01AI042023 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PARKS, GRIFFITH D. · 1998 to 2008
$1.7M
Anti-Bacterial Innate Responses Enhance Paramyxovirus ReplicationR21DC009619 · NIDCD · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PARKS, GRIFFITH D. · 2009 to 2010
$405k
NIAID NIH HHS AI42023NIAID NIH HHS R01 AI042023NIDCD NIH HHS DC009619NIDCD NIH HHS R21 DC009619
6 · The paper itself

Abstract

Macrophages regulate immune responses during many viral infections, and can be a major determinant of pathogenesis, virus replication and immune response to infection. Here, we have addressed the question of the outcome of infection of primary human macrophages with parainfluenza virus 5 (PIV5) and a PIV5 mutant (P/V-CPI-) that is unable to counteract interferon (IFN) responses. In cultures of naïve monocyte-derived macrophages (MDMs), WT PIV5 established a highly productive infection, whereas the P/V-CPI- mutant was restricted for replication in MDMs by IFN-beta. Restricted replication in vitro was relieved in MDM that had been activated by prior exposure to heat killed Gram positive bacteria, including Listeria monocytogenes, Streptococcus pyogenes, and Bacillus anthracis. Enhanced replication of the P/V mutant in MDM previously activated by bacterial components correlated with a reduced ability to produce IFN-beta in response to virus infection, whereas IFN signaling was intact. Activated MDM were found to upregulate the synthesis of IRAK-M, which has been previously shown to negatively regulate factors involved in TLR signaling and IFN-beta production. We discuss these results in terms of the implications for mixed bacteria-virus infections and for the use of live RNA virus vectors that have been engineered to be attenuated for IFN sensitivity.

Indexed as

Gram-Positive BacteriaMutationVirus ReplicationAnimalsChlorocebus aethiopsGene Expression Regulation, ViralHumansInterferon-betaInterleukin-1 Receptor-Associated KinasesMacrophage ActivationMacrophagesRespirovirusRespirovirus InfectionsSignal TransductionVero CellsInterferon-betaInterleukin-1 Receptor-Associated KinasesIRAK3 protein, human

Identifiers

PMID21185944
PMCPMC3056918
OpenAlexW2021630720

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.